The agency said the move reflected an updated analysis of the risk of a rare but serious blood-clotting condition in people who get the vaccine.
FDA Further Limits Johnson & Johnson Covid Vaccine
The agency said the move reflected an updated analysis of the risk of a rare but serious blood-clotting condition in people who get the vaccine.
Leave a Reply